BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 38581586)

  • 1. Overexpression of alpha synuclein disrupts APP and Endolysosomal axonal trafficking in a mouse model of synucleinopathy.
    Lin S; Leitão ADG; Fang S; Gu Y; Barber S; Gilliard-Telefoni R; Castro A; Sung K; Shen R; Florio JB; Mante ML; Ding J; Spencer B; Masliah E; Rissman RA; Wu C
    Neurobiol Dis; 2023 Mar; 178():106010. PubMed ID: 36702318
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rab11 modulates α-synuclein-mediated defects in synaptic transmission and behaviour.
    Breda C; Nugent ML; Estranero JG; Kyriacou CP; Outeiro TF; Steinert JR; Giorgini F
    Hum Mol Genet; 2015 Feb; 24(4):1077-91. PubMed ID: 25305083
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glucocerebrosidase activity and lipid levels are related to protein pathologies in Parkinson's disease.
    Leyns CEG; Prigent A; Beezhold B; Yao L; Hatcher NG; Tao P; Kang J; Suh E; Van Deerlin VM; Trojanowski JQ; Lee VMY; Kennedy ME; Fell MJ; Henderson MX
    NPJ Parkinsons Dis; 2023 May; 9(1):74. PubMed ID: 37169750
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A stem cell-based assay platform demonstrates alpha-synuclein dependent synaptic dysfunction in patient-derived cortical neurons.
    White AJ; Clark KA; Alexander KD; Ramalingam N; Young-Pearse TL; Dettmer U; Selkoe DJ; Ho GPH
    NPJ Parkinsons Dis; 2024 May; 10(1):107. PubMed ID: 38773105
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Near-Infrared Ratiometric Fluorescent Probe for Detecting Endogenous Cu
    Zhu J; Graziotto ME; Cottam V; Hawtrey T; Adair LD; Trist BG; Pham NTH; Rouaen JRC; Ohno C; Heisler M; Vittorio O; Double KL; New EJ
    ACS Sens; 2024 May; ():. PubMed ID: 38787339
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A critical reappraisal of current staging of Lewy-related pathology in human brain.
    Jellinger KA
    Acta Neuropathol; 2008 Jul; 116(1):1-16. PubMed ID: 18592254
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Altered TFEB subcellular localization in nigral neurons of subjects with incidental, sporadic and GBA-related Lewy body diseases.
    Moors TE; Morella ML; Bertran-Cobo C; Geut H; Udayar V; Timmermans-Huisman E; Ingrassia AMT; Brevé JJP; Bol JGJM; Bonifati V; Jagasia R; van de Berg WDJ
    Acta Neuropathol; 2024 Apr; 147(1):67. PubMed ID: 38581586
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The subcellular arrangement of alpha-synuclein proteoforms in the Parkinson's disease brain as revealed by multicolor STED microscopy.
    Moors TE; Maat CA; Niedieker D; Mona D; Petersen D; Timmermans-Huisman E; Kole J; El-Mashtoly SF; Spycher L; Zago W; Barbour R; Mundigl O; Kaluza K; Huber S; Hug MN; Kremer T; Ritter M; Dziadek S; Geurts JJG; Gerwert K; Britschgi M; van de Berg WDJ
    Acta Neuropathol; 2021 Sep; 142(3):423-448. PubMed ID: 34115198
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nuclear alpha-synuclein is present in the human brain and is modified in dementia with Lewy bodies.
    Koss DJ; Erskine D; Porter A; Palmoski P; Menon H; Todd OGJ; Leite M; Attems J; Outeiro TF
    Acta Neuropathol Commun; 2022 Jul; 10(1):98. PubMed ID: 35794636
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glucocerebrosidase regulators SCARB2 and TFEB are up-regulated in Lewy body disease brain.
    Pérez-Roca L; Prada-Dacasa P; Segú-Vergés C; Gámez-Valero A; Serrano-Muñoz MA; Santos C; Beyer K
    Neurosci Lett; 2019 Jul; 706():164-168. PubMed ID: 31116970
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical and pathological study on early diagnosis of Parkinson's disease and dementia with Lewy bodies].
    Orimo S
    Rinsho Shinkeigaku; 2008 Jan; 48(1):11-24. PubMed ID: 18386627
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multi-platform quantitation of alpha-synuclein human brain proteoforms suggests disease-specific biochemical profiles of synucleinopathies.
    Moors TE; Mona D; Luehe S; Duran-Pacheco G; Spycher L; Mundigl O; Kaluza K; Huber S; Hug MN; Kremer T; Ritter M; Dziadek S; Dernick G; van de Berg WDJ; Britschgi M
    Acta Neuropathol Commun; 2022 Jun; 10(1):82. PubMed ID: 35659116
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Classification of GBA1 Variants in Parkinson's Disease: The GBA1-PD Browser.
    Parlar SC; Grenn FP; Kim JJ; Baluwendraat C; Gan-Or Z
    Mov Disord; 2023 Mar; 38(3):489-495. PubMed ID: 36598340
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discrepancy between distribution of alpha-synuclein oligomers and Lewy-related pathology in Parkinson's disease.
    Sekiya H; Tsuji A; Hashimoto Y; Takata M; Koga S; Nishida K; Futamura N; Kawamoto M; Kohara N; Dickson DW; Kowa H; Toda T
    Acta Neuropathol Commun; 2022 Sep; 10(1):133. PubMed ID: 36068646
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.